Director Regulatory Affairs

Director Regulatory Affairs

Date:
Nov 24, 2025

Location:

St. Louis, MO, United States, 63146

Curium is the world’s largest nuclear medicine company with more than a century of industry experience. We develop, manufacture and distribute world‑class radiopharmaceutical products to help patients around the globe. Our proven heritage combined with a pioneering approach are the hallmarks to deliver innovation, excellence and unparalleled service.

With manufacturing facilities across Europe and the United States, Curium delivers SPECT, PET and therapeutic radiopharmaceutical solutions for life‑threatening diseases to over 14 million patients annually. The name ‘Curium’ honors the legacy of pioneering radioactive researchers Marie and Pierre Curie, after whom the radioactive element curium was named and emphasizes our focus on nuclear medicine. The tagline ‘Life Forward’ represents our commitment to securing a brighter future for all those we serve: an enhanced quality of care for our patients, a trusted partner to our customers, and a supportive employer to our valued team.

The Director of Regulatory Affairs is responsible for Nuclear Medicine Regulatory Affairs dossiers and associated regulatory affairs compliance and operations activities in the US. The responsibilities include, yet are not limited to, defining and authoring compliant content for new and existing dossiers, implementing and managing tracking systems, and preparation and submission of electronic drug, biologic, and device applications. The focus of this position is to lead new submissions associated with the chemistry of new chemical entities (NCE) as well as products already being tested in non‑clinical and/or clinical studies and focus on existing marketed products or those obtained through acquisition.

This position will facilitate the success of key regulatory projects that may require concept building, Target Product Profile (TPP), claims definition, regulatory strategy (including non‑clinical and clinical), non‑clinical and clinical protocol review, defining dossier Table of Contents, submission building, health authority management, obtaining approvals, managing post‑approval commitments, and product launch. It heads the Chemistry Manufacturing Controls dossier modules. The regional focus for project deliverables is North America (Food and Drug Administration and Health Canada), although the position will rely on the Canadian RA staff for country‑specific regulations.

The Director would lead project teams managing key projects, regulatory deliverables, prioritisation, strategy and tracking regulatory processes. The Director should be able to identify risk and make risk‑based decisions to facilitate solutions for process and submission. The candidate will direct and mentor less experienced staff on risk‑based decision making.

Work Schedule: Monday – Friday 8:00 am–5:00 pm

• Manage submissions and projects as assigned, ensuring compliance, planning, and execution.
• Process, interpret and provide recommendations for complex strategies.
• Critically review documentation for regulatory submissions and provide input for necessary revisions.
• Define Target Product Profile and build compliant drug and device "approvable" dossiers and registrations.
• Serve as liaison for third‑party service providers supporting Nuclear Medicine.
• Maintain associated compliance database for tracking individual and department project deliverables for new submissions and RA compliance.
• Implement policies, procedures, practices, and strategies for Regulatory Affairs.
• Develop and implement in alignment with regional RA taking local considerations into account.
• Manage multiple, sometimes conflicting priorities, define issues and obstacles, analyse risk and execute solutions.
• Execute objectives in alignment with Regulatory Head, Marketing and Global Business Units.
• Coordinate communication between the Global Business Units and the Regional Regulatory Affairs staff, resulting in a collaborative relationship.
• Communicate regulatory governmental policy changes to management in a timely manner and provide plans for meeting and complying…